Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif W Ellisen

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|September 15, 2017
A wound-healing program is hijacked to promote cancer metastasisLeif W Ellisen
Cell Cycle (Georgetown, Tex.)|November 1, 2005
Growth control under stress: mTOR regulation through the REDD1-TSC pathwayLeif W Ellisen
International Journal of Hematology|September 7, 2002
Regulation of gene expression by WT1 in development and tumorigenesisLeif W Ellisen
Cancer Cell|February 15, 2011
PARP inhibitors in cancer therapy: promise, progress, and puzzlesLeif W Ellisen
Cancer Cell|November 15, 2022
Loss of p53 and genetic evolution in pancreatic cancer: Ordered chaos after the guardian is goneBogang Wu, Leif W Ellisen
Oncotarget|March 26, 2011
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunityBenjamin Ory, Leif W Ellisen
The Oncologist|March 27, 2023
Revisiting Androgen Receptor Signaling in Breast CancerCharles Dai, Leif W Ellisen
Cancer Cell|March 11, 2025
Exploring the "chemo" in chemoimmunotherapy for triple-negative breast cancerTing Liu, Leif W Ellisen
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
mTOR activity under hypoxiaDouangsone D Vadysirisack, Leif W Ellisen
Cancer Cell|November 12, 2021
Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancerSiang-Boon Koh, Leif W Ellisen
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|September 15, 2017
A wound-healing program is hijacked to promote cancer metastasisLeif W Ellisen
Cell Cycle (Georgetown, Tex.)|November 1, 2005
Growth control under stress: mTOR regulation through the REDD1-TSC pathwayLeif W Ellisen
International Journal of Hematology|September 7, 2002
Regulation of gene expression by WT1 in development and tumorigenesisLeif W Ellisen
Cancer Cell|February 15, 2011
PARP inhibitors in cancer therapy: promise, progress, and puzzlesLeif W Ellisen
Cancer Cell|November 15, 2022
Loss of p53 and genetic evolution in pancreatic cancer: Ordered chaos after the guardian is goneBogang Wu, Leif W Ellisen
Oncotarget|March 26, 2011
A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunityBenjamin Ory, Leif W Ellisen
The Oncologist|March 27, 2023
Revisiting Androgen Receptor Signaling in Breast CancerCharles Dai, Leif W Ellisen
Cancer Cell|March 11, 2025
Exploring the "chemo" in chemoimmunotherapy for triple-negative breast cancerTing Liu, Leif W Ellisen
Methods in Molecular Biology (Clifton, N.J.)|November 30, 2011
mTOR activity under hypoxiaDouangsone D Vadysirisack, Leif W Ellisen
Cancer Cell|November 12, 2021
Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancerSiang-Boon Koh, Leif W Ellisen
Pageof 12